VC Sift
Get started free

BioTech Investors

4,602 investors · 3,559 with verified email

VCSift lists 4,602 BioTech investors, from angels writing first checks to growth funds. 3,559 of them have a verified email address on file. They include 2,166 VC firms, 2,085 angel investors and 92 accelerators. The largest groups are based in United States (588), China (179) and South Korea (74). Stages with the most investors: Seed (2,840), Growth (1,900) and Pre-Seed (519). Firms with the most BioTech investors on VCSift include Salesforce, Andreessen Horowitz and Insight Partners. Use the stage and country lists below to narrow this down to investors who match your round.

4,602 investors
FH

Felda Hardymon

Bessemer Venture Partners

VC Firm
Pre-Seed Seed Crypto Web3 Blockchain Small And Medium Businesses Marketplaces +7 more
JW

Jessie Wang

Predicine Holdings

Angel Investor
Early Stage Biotechnology
JB

Jeremy Blitzer

Angel / Independent

Angel Investor
Seed Biotechnology Pharmaceuticals
AC

Alice Chen

Angel / Independent

Angel Investor
Seed Biotechnology
PS

Peter Segall

Insight Partners

Angel Investor
Early Stage Growth Big Data Small And Medium Businesses Marketplaces +7 more
NT

Nelson Teng

GSR Ventures

VC Firm
Seed Early Stage Big Data Investment Management Biotechnology +7 more
DB

David Bill

Angel / Independent

Angel Investor
Seed Crypto Web3 Blockchain Marketplaces Security Privacy +7 more
BH

Brent Hoberman

Angel / Independent

Angel Investor
Seed Crypto Web3 Blockchain It Management Biotechnology +6 more
BA

Bauke Anninga

M Ventures

VC Firm
Seed Early Stage Investment Management Biotechnology Digital Health +4 more
SB

Securitas Biosciences

VC Firm
Series A BioTech
ST

Startup Trakya

Luleburgaz, Turkey VC Firm
BioTech SaaS
IT

Immune Therapy Holdings

Stockholm, Sweden VC Firm
Fintech BioTech
MP

Mstone Partners Healthcare

VC Firm
AI/ML HealthTech BioTech
AC

AccessBioVentures

VC Firm
BioTech
FV

FMG Ventures

VC Firm
HealthTech BioTech
PF

Polymer Forge

Madison, US VC Firm
HealthTech BioTech
XU

Xuture

Mountain View, US VC Firm
Series A Seed BioTech
UC

UVB Capital

Salt Lake City, US VC Firm
Fintech HealthTech BioTech
JU

Jubea

Remoulins, France VC Firm
Fintech BioTech
IT

Ischemia Technologies

Waltham, US VC Firm
HealthTech BioTech
CB

CEBINA Bridge Capital

Gibraltar, Gibraltar Private Equity
Series A BioTech
KB

Korea Bio Association

Seongnam, South Korea VC Firm
BioTech
IH

ICW Healthcare Ventures

New York, US VC Firm
Fintech BioTech
JW

Jiangsu Wanbang Biochemical Pharmaceuticals Co. Ltd

Shanghai, China VC Firm
BioTech
WG

Walter Greenblatt & Associates

Princeton, US Private Equity
BioTech
TA

Triphase Accelerator Corporation

La Jolla, US Accelerator
Fintech BioTech
BH

Bladder Health Ventures

Jackson, US Corporate VC
HealthTech BioTech
IA

Insight Accelerator Labs

Chicago, US Accelerator
Seed HealthTech BioTech
MM

Mina Mar Group

Newark, US Private Equity
Fintech BioTech
NG

Nascent Group Holdings llc.

Columbus, US Private Equity
Growth Series A HealthTech BioTech PropTech
AB

Astor Birri

Palo Alto, US Family Office
Growth Seed AI/ML Fintech BioTech
BV

Bija Ventures

Aspen, US VC Firm
Seed BioTech
MG

Menarini Group

Firenze, Italy VC Firm
HealthTech BioTech
IU

Indiana University Research & Technology

Indianapolis, US VC Firm
BioTech EdTech
CS

Camino Science

Bialystok, Poland VC Firm
AI/ML BioTech
AF

Augusta Fermentation Qualified Opportunity Fund

Augusta, US VC Firm
BioTech
BK

Blue Kite Capital

Irvine, US VC Firm
Fintech BioTech CleanTech
SA

Salus

Ljubljana, Slovenia VC Firm
BioTech
NI

Nippi

Tokyo, Japan VC Firm
HealthTech BioTech
EL

Elpis

Waterloo, Canada VC Firm
HealthTech BioTech
KT

Kawin Technology

Beijing, China VC Firm
HealthTech BioTech
ZP

Zhangzhou Pientzehuang Pharmaceutical

Zhangzhou, China VC Firm
HealthTech BioTech
BS

Beijing Strong Biotechnologies

Haidian, China VC Firm
HealthTech BioTech
DP

Dechra Pharmaceuticals

Northwich, UK VC Firm
BioTech
SK

Shanghai Kehua Bio-engineering Co.

Shanghai, China VC Firm
HealthTech BioTech
TS

THO Seed Fund

Creve Coeur, US VC Firm
BioTech
KO

Kolinpharma

Lainate, Italy VC Firm
HealthTech BioTech
CP

CFR Pharmaceuticals

Santiago, Chile VC Firm
BioTech
ST

Shanghai Tellgen Life Science

Pudong, China VC Firm
BioTech
CB

Chiome Bioscience

Tokyo, Japan VC Firm
HealthTech BioTech

BioTech investors by stage

Seed (2,840) Growth (1,900) Pre-Seed (519) Series A (292) Series C (108)

BioTech investors by country

United States (588) China (179) South Korea (74) United Kingdom (71) Japan (58) Canada (45) Germany (42) Switzerland (38) India (28) France (28) Italy (26) Israel (24)

Firms with the most BioTech investors

Salesforce (62) Andreessen Horowitz (62) Insight Partners (61) Bessemer Venture Partners (36) Sanofi (30) Sequoia Capital China (24) Sanofi Aventis (22) Forbion Capital Partners (22)

Frequently asked questions about BioTech investors

4,602 as of November 2026, 3,559 of them with a verified email address. They include 2,166 VC firms, 2,085 angel investors and 92 accelerators.
The largest groups are based in United States (588), China (179) and South Korea (74). Use the country lists on this page to see investors in a specific market.
Stages with the most investors: Seed (2,840), Growth (1,900), Pre-Seed (519), Series A (292) and Series C (108). Pick the stage page that matches your round before reaching out.
Firms with the most BioTech investors on VCSift include Salesforce, Andreessen Horowitz, Insight Partners, Bessemer Venture Partners and Sanofi. Each firm page lists its partners and investors with their titles and contact details.
Yes. VCSift Essentials subscribers can export up to 1,000 contacts per month as a CSV, and Pro subscribers have unlimited exports. Each row includes name, firm, title, email, LinkedIn URL, stages, sectors and location.
VCSift re-verifies email addresses on a rolling basis, removes bounced addresses, and merges new investors from public filings and firm websites. Profiles show a last-verified date where one exists.

Browse the investor directory

Pre-Seed investors Seed investors Series A investors Series B investors Series C investors Series C+ investors Growth investors Late Stage investors Investors in United States Investors in United Kingdom Investors in Germany Investors in India Investors in Singapore Investors in Canada Investors in France Investors in Israel Investors in Australia Investors in The Netherlands Angel investors VC firms Family offices Accelerators